Pabatang, Imie T.
HRN: 02-97-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
CEFUROXIME 500MG (TAB)
12/16/2025
12/23/2025
PO
500mg
BID X 7 Days
S/P RMLE And Repair
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes